Pharmacoutilization and adherence to sacubitril/valsartan in real world: the REAL.IT study in HFrEF.

Massimo Iacoviello,Gabriele Di Gesaro,Filippo Maria Sarullo,Daniela Miani,Mauro Driussi,Michele Correale,Claudio Bilato, Andrea Passantino,Erberto Carluccio,Alessandra Villani,Luca Degli Esposti,Chiara d'Agostino,Elena Peruzzi,Simone Poli,Andrea di Lenarda

ESC heart failure（2023）

引用 0|浏览4

暂无评分

摘要

Real-world data on the use of sacubitril/valsartan in clinical practice in Italy show a rapid titration to the target dose, high therapeutic adherence enabling a good level of therapeutic management in line with ESC guidelines for patients with reduced ejection fraction.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要